Madison Ford is a Research Analyst at the Tufts Center for the Study of Drug Development, where she conducts research on decentralized clinical trial solutions, patient-centric clinical trial design, minority participation, clinical trial rigor, and change management initatives. She also manages the Assessment workstream for the PALADIN Consortium, supporting collaborative efforts to advance clinical trial innovation. Her work includes survey and database design, quantitative and qualitative data analysis, literature reviews, and stakeholder engagement. Madison earned a BS in Public Health from The University of Alabama and an MPH in Health Management and Policy from Georgia State University.
Abigail Dirks is a Data Scientist at the Tufts Center for the Study of Drug Development (Tufts CSDD) where she specializes in analyzing large datasets pertaining to industry drug development performance, including clinical research associate (CRA) performance, impact of decentralized clinical trials (DCT), and investigative site burden. She recently received her Master’s in Health Informatics and Analytics from Tufts University and has a BS in Data Science and Mathematics from St. Michael’s College. She also has experience in web development for North Shore Nurse Practitioner Associates, a psychopharmacology practice.
Dr. Jennifer Y. Kim is a behavioral scientist and Research Associate Professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine, who studies how to optimize drug development by combining organizational behavior, social psychology, and clinical research. She examines the behaviors, attitudes, and experiences of key stakeholders involved in bringing new therapies to patients, from drug development professionals and clinical research staff to the patients themselves, to improve the quality and inclusivity of clinical research. Her work has been published in Nature Biotechnology, JAMA Network Open, and Harvard Business Review. Outside of research, she enjoys hiking, archery, and scuba diving.
Ken Getz is the Executive Director and a research professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine, where he conducts grant-funded research on pharmaceutical R&D management and execution; protocol design optimization; contract service provider and investigative site management; e-clinical technology and data usage; and patient and community engagement. He is also the chairman of CISCRP – a nonprofit internationally-recognized organization that he founded to educate and raise public and patient awareness of the clinical research enterprise. And the president of the Otsuka Patient Assistance Foundation. A well-known speaker at conferences, symposia, universities, investor meetings and corporations, Ken has published extensively in peer-review journals, books and in the trade press and writes a bi-monthly column nominated for a Neal Award in Applied Clinical Trials. He holds a number of board appointments in the private and public sectors and serves on the editorial boards of Pharmaceutical Medicine, Life Science Leader and Therapeutic Innovation and Regulatory Science. Ken received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree, Phi Beta Kappa, from Brandeis University. He is the founder of CenterWatch, a leading publisher in the clinical trials industry, and one of several businesses that he has created and sold.
Experienced Head Of Project Management with a demonstrated history of working in the research industry. Skilled in Business Planning, Customer Acquisition, Medical Devices, Communication, and Oncology. Strong healthcare services professional with a Diploma of advanced studies in Pharmaceutical Medicine (DAS) focused in ECPM from Universität Basel.
Internationally experienced healthcare in-house lawyer and certified EU Data Privacy expert with substantial expertise support broad Research and Development activities and general Corporate matters in biotech organization. Subject matter expert in full scope of commercial, research, IP and clinical contracts including development and review of informed consent forms in ethics and regulatory approval processes.
Pharmaceutical professional with a strong background in preclinical research and a strategic focus on patient engagement. I have experience across the drug development, from early-stage research to patient-centered initiatives, allowing me to bridge the gap between science and real-world healthcare needs. My expertise includes executing preclinical studies, interpreting complex scientific data, and translating research insights into meaningful outcomes.
In recent years, I have shifted my focus toward patient engagement, working to integrate the patient voice into drug development processes. I am passionate about fostering collaboration between researchers, healthcare providers, and patients to ensure that treatments are not only scientifically sound but also aligned with patient needs and experiences. My ability to navigate both the scientific and human aspects of pharmaceutical development enables me to contribute to innovate.
